Boston Scientific Corporation
BSX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $20.1B | $16.7B | +19.9% |
| Operating income | $3.61B | $2.60B | +38.8% |
| Net income | $2.90B | $1.85B | +56.4% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 2, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $5.14B | $5.07B | +1.4% |
| Operating income | $828M | $1.05B | −21.0% |
| Net income | $580M | $755M | −23.2% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Boston Scientific's revenue in FY2025?
- $20.1B in FY2025 (Fiscal year ended Dec 31, 2025), +19.9% vs $16.7B a year earlier, per its 10-K filed Feb 2026.
- Was Boston Scientific profitable in FY2025?
- Yes: net income was $2.90B and operating income $3.61B in FY2025.
- What was Boston Scientific's revenue in Q3 2026?
- $5.14B (+1.4% vs a year earlier), per its Form 10-Q filed Nov 2, 2026.